Kezar Life Sciences
Stock Forecast, Prediction & Price Target
Kezar Life Sciences (KZR) stock Price Target by analysts
$9
Potential upside: 132.52%
Kezar Life Sciences price prediction
What is Kezar Life Sciences stock analysts` prediction?
Kezar Life Sciences stock forecast: Based on 1 Wall Street analysts` predicted price targets for Kezar Life Sciences in the last 3 months, the avarage price target is $9, with a high forecast of $NaN. The average price target represents a 132.52% change from the last price of $3.87.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Kezar Life Sciences stock Price Target by analysts
Full breakdown of analysts given Kezar Life Sciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Derek Archila Wells Fargo | 0% 0/1 | 9 months ago | $9 132.52% upside | $6.26 | TheFly | Previous targets (0) |
Unknown H.C. Wainwright | N/A | about 3 years ago | $21 442.55% upside | $9.76 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $14 261.70% upside | $7.94 | Benzinga | N/A |
Kezar Life Sciences Financial Estimates
Kezar Life Sciences Revenue Estimates
Kezar Life Sciences EBITDA Estimates
Kezar Life Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $7M 0% | Avg: $3.33M Low: $3.33M High: $3.33M avg. -52.38% | Avg: $7M Low: $7M High: $7M avg. 110.00% | Avg: $21M Low: $21M High: $21M avg. 200% | Avg: $31.5M Low: $31.5M High: $31.5M avg. 50% |
Net Income
% change YoY
| $-53.27M N/A | $-65.31M -22.59% | $-101.87M -55.96% | Avg: $-106.21M Low: $-114.63M High: $-61.67M avg. -4.26% | Avg: $-130.51M Low: $-122.61M High: $-52.23M avg. -22.87% | Avg: $-93.83M Low: $-93.83M High: $-93.83M avg. 28.10% | Avg: $-60.58M Low: $-60.58M High: $-60.58M avg. 35.43% |
EBITDA
% change YoY
| $-54.47M N/A | $-71.16M -30.64% | $-99.25M -39.47% | Avg: $1.99M Low: $1.99M High: $1.99M avg. 102.01% | Avg: $4.2M Low: $4.2M High: $4.2M avg. 110.00% | Avg: $12.6M Low: $12.6M High: $12.6M avg. 200% | Avg: $18.9M Low: $18.9M High: $18.9M avg. 50% |
EPS
% change YoY
| -$1.01 N/A | -$0.97 3.96% | -$1.4 -44.32% | Avg: -$1.22 Low: -$1.58 High: -$0.85 avg. 12.61% | Avg: -$1.27 Low: -$1.69 High: -$0.72 avg. -3.81% | Avg: -$1.29 Low: -$1.29 High: -$1.29 avg. -1.83% | Avg: -$0.84 Low: -$0.84 High: -$0.84 avg. 35.43% |
Operating Expenses
% change YoY
| $54.65M N/A | $71.16M 30.19% | $118.42M 66.41% | Avg: $5.09M Low: $5.09M High: $5.09M avg. -95.69% | Avg: $10.69M Low: $10.69M High: $10.69M avg. 110.00% | Avg: $32.08M Low: $32.08M High: $32.08M avg. 200% | Avg: $48.12M Low: $48.12M High: $48.12M avg. 50% |
FAQ
What is Kezar Life Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 9.09% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -114.63M, average is -106.21M and high is -61.67M.
What is Kezar Life Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 76.90% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $3.33M, average is $3.33M and high is $3.33M.
What is Kezar Life Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 10.60% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$1.58, average is -$1.22 and high is $-0.85.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Kezar Life Sciences stock. The most successful analyst is Derek Archila.